These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 19178667

  • 1. Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference?
    Marconato L, Bonfanti U, Stefanello D, Lorenzo MR, Romanelli G, Comazzi S, Zini E.
    Vet Comp Oncol; 2008 Jun; 6(2):80-9. PubMed ID: 19178667
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
    Simon D, Moreno SN, Hirschberger J, Moritz A, Kohn B, Neumann S, Jurina K, Scharvogel S, Schwedes C, Reinacher M, Beyerbach M, Nolte I.
    J Am Vet Med Assoc; 2008 Mar 15; 232(6):879-85. PubMed ID: 18341445
    [Abstract] [Full Text] [Related]

  • 3. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
    Valerius KD, Ogilvie GK, Mallinckrodt CH, Getzy DM.
    J Am Vet Med Assoc; 1997 Feb 15; 210(4):512-6. PubMed ID: 9040837
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases.
    Sorenmo K, Overley B, Krick E, Ferrara T, LaBlanc A, Shofer F.
    Vet Comp Oncol; 2010 Sep 15; 8(3):196-208. PubMed ID: 20691027
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
    Daters AT, Mauldin GE, Mauldin GN, Brodsky EM, Post GS.
    Vet Comp Oncol; 2010 Mar 15; 8(1):11-22. PubMed ID: 20230577
    [Abstract] [Full Text] [Related]

  • 7. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs.
    Zenker I, Meichner K, Steinle K, Kessler M, Hirschberger J.
    Vet Rec; 2010 Nov 06; 167(19):744-8. PubMed ID: 21257510
    [Abstract] [Full Text] [Related]

  • 8. Autologous marrow transplantation as consolidation therapy for canine lymphoma: efficacy and toxicity of various regimens of total body irradiation.
    Deeg HJ, Appelbaum FR, Weiden PL, Hackman RC, Graham TC, Storb RC.
    Am J Vet Res; 1985 Sep 06; 46(9):2016-8. PubMed ID: 3901841
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy in canine acute megakaryoblastic leukemia: a case report and review of the literature.
    Willmann M, Müllauer L, Schwendenwein I, Wolfesberger B, Kleiter M, Pagitz M, Hadzijusufovic E, Shibly S, Reifinger M, Thalhammer JG, Valent P.
    In Vivo; 2009 Sep 06; 23(6):911-8. PubMed ID: 20023232
    [Abstract] [Full Text] [Related]

  • 10. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997).
    Zwahlen CH, Lucroy MD, Kraegel SA, Madewell BR.
    J Am Vet Med Assoc; 1998 Oct 15; 213(8):1144-9. PubMed ID: 9787382
    [Abstract] [Full Text] [Related]

  • 11. Treatment of canine lymphoma with COPLA/LVP.
    Boyce KL, Kitchell BE.
    J Am Anim Hosp Assoc; 2000 Oct 15; 36(5):395-403. PubMed ID: 10997514
    [Abstract] [Full Text] [Related]

  • 12. Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs.
    Northrup NC, Gieger TL, Kosarek CE, Saba CF, LeRoy BE, Wall TM, Hume KR, Childress MO, Keys DA.
    Vet Comp Oncol; 2009 Mar 15; 7(1):38-44. PubMed ID: 19222829
    [Abstract] [Full Text] [Related]

  • 13. Comparison of COAP and UW-19 protocols for dogs with multicentric lymphoma.
    Hosoya K, Kisseberth WC, Lord LK, Alvarez FJ, Lara-Garcia A, Kosarek CE, London CA, Couto CG.
    J Vet Intern Med; 2007 Mar 15; 21(6):1355-63. PubMed ID: 18196747
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.
    Ponce F, Magnol JP, Ledieu D, Marchal T, Turinelli V, Chalvet-Monfray K, Fournel-Fleury C.
    Vet J; 2004 Mar 15; 167(2):158-66. PubMed ID: 14975390
    [Abstract] [Full Text] [Related]

  • 15. [Therapeutic effects of chemotherapeutic regimens containing pirarubicin on the treatment of high-risk or refractory and relapsed acute leukemia in adults].
    Li QH, DU X, Huang ZL, Luo CW, Zhong LY, Lin W.
    Zhonghua Yi Xue Za Zhi; 2005 May 11; 85(17):1195-7. PubMed ID: 16029595
    [Abstract] [Full Text] [Related]

  • 16. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
    Estlin EJ, Yule SM, Lowis SP.
    Cancer Treat Rev; 2001 Dec 11; 27(6):339-50. PubMed ID: 11908927
    [Abstract] [Full Text] [Related]

  • 17. In vitro immune monitoring of antibody response in dogs given chemoimmunotherapy for lymphoma.
    Jeglum KA, Winters WD, Young KM.
    Am J Vet Res; 1989 Apr 11; 50(4):488-92. PubMed ID: 2712415
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy versus chemotherapy with intralymphatic tumor cell vaccine in canine lymphoma.
    Jeglum KA, Young KM, Barnsley K, Whereat A.
    Cancer; 1988 May 15; 61(10):2042-50. PubMed ID: 3359402
    [Abstract] [Full Text] [Related]

  • 19. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.
    Zemann BI, Moore AS, Rand WM, Mason G, Ruslander DM, Frimberger AE, Wood CA, L'Heureux DA, Gliatto J, Cotter SM.
    J Vet Intern Med; 1998 May 15; 12(6):465-70. PubMed ID: 9857340
    [Abstract] [Full Text] [Related]

  • 20. Weekly administration of low-dose doxorubicin for treatment of malignant lymphoma in dogs.
    Ogilvie GK, Vail DM, Klein MK, Powers BE, Dickinson K.
    J Am Vet Med Assoc; 1991 May 15; 198(10):1762-4. PubMed ID: 2071476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.